MAPT and early-onset autosomal dominant Alzheimer disease: Nevertheless, these mouse models still have some limitations as they exhibit less Alzheimer’s disease-related tau pathology.30 Another shortcoming in our setup is the modest number of the memory clinic cohort and follow-up data of participants.